The ASA now recognises pharyngeal electrical stimulation’s benefit in treating patients who experience difficulty swallowing following a stroke.
Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing difficulty swallowing post-stroke, welcomed the 2026 Guideline for the Early ...
MANCHESTER, England, April 20, 2021 /PRNewswire/ -- Phagenesis Ltd, a private healthcare company offering an innovative treatment for dysphagia, announces successful treatment of intubation–induced ...
Scientists at Trinity College Dublin have discovered that electrically stimulating macrophages can “reprogram” them in such a way to reduce inflammation and encourage faster, more effective healing in ...